No abstract available
MeSH terms
-
Coronary Restenosis / complications
-
Coronary Thrombosis / complications*
-
Coronary Thrombosis / epidemiology
-
Drug-Eluting Stents / adverse effects*
-
Drug-Eluting Stents / standards
-
Endothelium, Vascular / pathology
-
Fibrinolytic Agents / therapeutic use
-
Humans
-
Incidence
-
Platelet Activation / physiology*
-
Platelet Aggregation Inhibitors / therapeutic use
-
Stents / adverse effects*
-
Thrombosis / etiology
-
Thrombosis / physiopathology*
-
Thrombosis / prevention & control
-
von Willebrand Factor / metabolism
Substances
-
Fibrinolytic Agents
-
Platelet Aggregation Inhibitors
-
von Willebrand Factor